CDC issues updated opioid prescribing guideline for comment
The Centers for Disease Control and Prevention is accepting comments through April 11 on a draft updated clinical practice guideline for prescribing opioids for chronic pain. The guideline recommendations are voluntary and intended to improve communication between providers and patients and empower them to make informed, patient-centered decisions related to safe and effective pain care, CDC said. For more on the process and timeline for updating the guideline, click here.
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…